• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃肠道癌前状况及其检测。

Gastrointestinal Cancer Precursor Conditions and Their Detection.

机构信息

Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA; Harvard Medical School, Boston, MA, USA. Electronic address: https://twitter.com/asaf_maoz.

Harvard Medical School, Boston, MA, USA; Division of Gastroenterology, Hepatology and Endoscopy, Brigham and Women's Hospital, 75 Francis Street, Boston MA 02115, USA; Division of Cancer Genetics and Prevention, 450 Brookline Avenue, Boston MA 02215, USA. Electronic address: https://twitter.com/Dr_NJRodriguez.

出版信息

Hematol Oncol Clin North Am. 2024 Aug;38(4):783-811. doi: 10.1016/j.hoc.2024.04.002. Epub 2024 May 17.

DOI:10.1016/j.hoc.2024.04.002
PMID:38760197
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11537157/
Abstract

Gastrointestinal cancers are a leading cause of cancer morbidity and mortality. Many gastrointestinal cancers develop from cancer precursor lesions, which are commonly found in individuals with hereditary cancer syndromes. Hereditary cancer syndromes have advanced our understanding of cancer development and progression and have facilitated the evaluation of cancer prevention and interception efforts. Common gastrointestinal hereditary cancer syndromes, including their organ-specific cancer risk and surveillance recommendations, are reviewed in this article. The management of common gastroesophageal, pancreatic, and colonic precursor lesions is also discussed, regardless of their genetic background. Further research is needed to advance chemoprevention and immunoprevention strategies.

摘要

胃肠道癌症是癌症发病率和死亡率的主要原因。许多胃肠道癌症源自癌前病变,这些病变在遗传性癌症综合征患者中很常见。遗传性癌症综合征使我们对癌症的发生和发展有了更深入的了解,并有助于评估癌症的预防和干预措施。本文回顾了常见的胃肠道遗传性癌症综合征,包括其特定于器官的癌症风险和监测建议。本文还讨论了常见的胃食管、胰腺和结肠前体病变的治疗,无论其遗传背景如何。需要进一步的研究来推进化学预防和免疫预防策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c1/11537157/be61ab40b487/nihms-2026477-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c1/11537157/e00b6703a10f/nihms-2026477-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c1/11537157/be61ab40b487/nihms-2026477-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c1/11537157/e00b6703a10f/nihms-2026477-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c1/11537157/be61ab40b487/nihms-2026477-f0002.jpg

相似文献

1
Gastrointestinal Cancer Precursor Conditions and Their Detection.胃肠道癌前状况及其检测。
Hematol Oncol Clin North Am. 2024 Aug;38(4):783-811. doi: 10.1016/j.hoc.2024.04.002. Epub 2024 May 17.
2
Hereditary Gastrointestinal Cancer Syndromes: Role of Imaging in Screening, Diagnosis, and Management.遗传性胃肠道癌症综合征:影像学在筛查、诊断和管理中的作用。
Radiographics. 2019 Sep-Oct;39(5):1280-1301. doi: 10.1148/rg.2019180185. Epub 2019 Aug 2.
3
ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes.ACG 临床指南:遗传性胃肠道癌综合征的基因检测与管理。
Am J Gastroenterol. 2015 Feb;110(2):223-62; quiz 263. doi: 10.1038/ajg.2014.435. Epub 2015 Feb 3.
4
Hereditary Cancer Syndromes-A Primer on Diagnosis and Management, Part 2: Gastrointestinal Cancer Syndromes.遗传性癌症综合征——诊断和管理基础,第 2 部分:胃肠道癌症综合征。
Mayo Clin Proc. 2019 Jun;94(6):1099-1116. doi: 10.1016/j.mayocp.2019.01.042.
5
Hereditary gastrointestinal carcinomas and their precursors: An algorithm for genetic testing.遗传性胃肠道癌及其前驱病变:基因检测算法
Semin Diagn Pathol. 2018 May;35(3):170-183. doi: 10.1053/j.semdp.2018.01.004. Epub 2018 Jan 31.
6
Screening and surveillance in hereditary gastrointestinal cancers: Recommendations from the European Society of Digestive Oncology (ESDO) expert discussion at the 20th European Society for Medical Oncology (ESMO)/World Congress on Gastrointestinal Cancer, Barcelona, June 2018.遗传性胃肠道癌症的筛查和监测:2018 年 6 月在巴塞罗那举行的第 20 届欧洲肿瘤内科学会(ESMO)/世界胃肠癌大会上,欧洲消化肿瘤学会(ESDO)专家讨论的建议。
Eur J Cancer. 2018 Nov;104:91-103. doi: 10.1016/j.ejca.2018.09.004. Epub 2018 Oct 18.
7
[Role of the PRED-IdF, a regional network dedicated to patients with hereditary predisposition to digestive cancers].[PRED-IdF的作用,一个致力于遗传性消化癌症易感性患者的区域网络]
Ann Pathol. 2020 Apr;40(2):114-119. doi: 10.1016/j.annpat.2020.02.026. Epub 2020 Mar 18.
8
Gastrointestinal polyposis with associated cutaneous manifestations.伴有相关皮肤表现的胃肠道息肉病。
Pathology. 2022 Mar;54(2):157-166. doi: 10.1016/j.pathol.2021.08.009. Epub 2021 Nov 9.
9
Pediatric Cancer Screening in Hereditary Gastrointestinal Cancer Risk Syndromes: An Update from the AACR Childhood Cancer Predisposition Working Group.遗传性胃肠道癌风险综合征中的儿科癌症筛查:AACR 儿童癌症易感性工作组的最新进展。
Clin Cancer Res. 2024 Oct 15;30(20):4566-4571. doi: 10.1158/1078-0432.CCR-24-0953.
10
Genetic testing in gastroenterology. Preface.胃肠病学中的基因检测。前言。
Best Pract Res Clin Gastroenterol. 2009;23(2):125-6. doi: 10.1016/j.bpg.2009.03.004.

本文引用的文献

1
Next-Generation Multitarget Stool DNA Test for Colorectal Cancer Screening.用于结直肠癌筛查的下一代多靶点粪便 DNA 检测。
N Engl J Med. 2024 Mar 14;390(11):984-993. doi: 10.1056/NEJMoa2310336.
2
A Cell-free DNA Blood-Based Test for Colorectal Cancer Screening.基于无细胞游离 DNA 的血液检测用于结直肠癌筛查。
N Engl J Med. 2024 Mar 14;390(11):973-983. doi: 10.1056/NEJMoa2304714.
3
International evidence-based Kyoto guidelines for the management of intraductal papillary mucinous neoplasm of the pancreas.国际循证京都指南:胰腺导管内乳头状黏液性肿瘤的管理。
Pancreatology. 2024 Mar;24(2):255-270. doi: 10.1016/j.pan.2023.12.009. Epub 2023 Dec 28.
4
Revisiting Proton Pump Inhibitors as Chemoprophylaxis Against the Progression of Barrett's Esophagus.重新审视质子泵抑制剂在预防 Barrett 食管进展中的化学预防作用。
Curr Gastroenterol Rep. 2023 Dec;25(12):374-379. doi: 10.1007/s11894-023-00905-5. Epub 2023 Nov 9.
5
Genetic predisposition to gastrointestinal polyposis: syndromes, tumour features, genetic testing, and clinical management.胃肠道息肉病的遗传易感性:综合征、肿瘤特征、基因检测及临床管理
Lancet Gastroenterol Hepatol. 2024 Jan;9(1):68-82. doi: 10.1016/S2468-1253(23)00240-6. Epub 2023 Nov 4.
6
Neoplasia risk in patients with Lynch syndrome treated with immune checkpoint blockade.林奇综合征患者接受免疫检查点阻断治疗的肿瘤风险。
Nat Med. 2023 Oct;29(10):2458-2463. doi: 10.1038/s41591-023-02544-9. Epub 2023 Oct 16.
7
AGA Clinical Practice Update on Risk Stratification for Colorectal Cancer Screening and Post-Polypectomy Surveillance: Expert Review.AGA 临床实践更新:结直肠癌筛查和息肉切除术后监测的风险分层:专家综述。
Gastroenterology. 2023 Nov;165(5):1280-1291. doi: 10.1053/j.gastro.2023.06.033. Epub 2023 Sep 21.
8
Integrated Molecular Characterization of Intraductal Papillary Mucinous Neoplasms: An NCI Cancer Moonshot Precancer Atlas Pilot Project.导管内乳头状黏液性肿瘤的综合分子特征:NCI 癌症登月计划癌前图谱试点项目。
Cancer Res Commun. 2023 Oct 10;3(10):2062-2073. doi: 10.1158/2767-9764.CRC-22-0419.
9
Germline Determinants of Esophageal Adenocarcinoma.食管腺癌的生殖系决定因素
Gastroenterology. 2023 Nov;165(5):1276-1279.e7. doi: 10.1053/j.gastro.2023.07.015. Epub 2023 Jul 26.
10
Prevalence and Clinical Implications of Mismatch Repair-Proficient Colorectal Cancer in Patients With Lynch Syndrome.林奇综合征患者中错配修复功能完整的结直肠癌的流行情况及其临床意义。
JCO Precis Oncol. 2023 May;7:e2200675. doi: 10.1200/PO.22.00675.